Marketed products

Most of the SC therapies on the market and in development utilize MSCs. At least three osteobiologic products, Osteocel (NuVasive), Trinity (Orthofix) and LiquidGen (Skye Orthbiologics), use MSCs as a component of an allograft matrix and are believed to promote osteogenesis and reduce inflammation. SC grafts are the fastest-growing area of the bone graft market, with a projected value of US$600 million by 2015.

Enjoying our latest content?
Log in or create an account to continue

  • Access the most recent journalism from Nature's award-winning team
  • Explore the latest features & opinion covering groundbreaking research
Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD